Remission Status Predicts Work-Related Outcomes for Patients With Mild-to-Moderate Ulcerative Colitis Receiving Short-Term and Long-Term Daily Therapy With Multimatrix Mesalamine: 1935
Yarlas, Aaron, DʼHaens, Geert, Willshire, Deborah, Teynor, Megan
Published in The American journal of gastroenterology (01.10.2015)
Published in The American journal of gastroenterology (01.10.2015)
Get full text
Journal Article
Remission Status Predicts Health-Related Quality of Life for Patients With Mild-to-Moderate Ulcerative Colitis Receiving Short-Term and Long-Term Daily Therapy With Multimatrix Mesalamine: 1945
Yarlas, Aaron, DʼHaens, Geert, Willshire, Deborah, Teynor, Megan
Published in The American journal of gastroenterology (01.10.2015)
Published in The American journal of gastroenterology (01.10.2015)
Get full text
Journal Article
Long-term Pooled Safety Analysis of Once-Daily Multimatrix Mesalamine: 1740
Sanchez, Susana Silva, Wan, Hong, Streck, Paul, Willshire, Deborah, Raskin, Jeffrey
Published in The American journal of gastroenterology (01.10.2014)
Published in The American journal of gastroenterology (01.10.2014)
Get full text
Journal Article